Indoco’s US Business Grows After Azopt Rival Launch

Company Aims To Launch 20 Products A Year By 2023

 
• By Akriti Seth
INR_Dollar
Indoco’s US revenues grow on the back of the launch of generic version of Novartis’ Azopt • Source: Alamy

More from Generics

More from Products